Avestar Capital LLC Has $466,000 Stock Position in Colgate-Palmolive (NYSE:CL)

Avestar Capital LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 9.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,493 shares of the company’s stock after buying an additional 394 shares during the quarter. Avestar Capital LLC’s holdings in Colgate-Palmolive were worth $466,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of CL. Brooklyn Investment Group grew its holdings in Colgate-Palmolive by 8.5% in the third quarter. Brooklyn Investment Group now owns 5,159 shares of the company’s stock worth $536,000 after purchasing an additional 406 shares during the period. FMR LLC boosted its position in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Colgate-Palmolive by 36.9% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 954,570 shares of the company’s stock valued at $99,094,000 after buying an additional 257,361 shares during the period. Horizon Kinetics Asset Management LLC increased its position in Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after buying an additional 124 shares in the last quarter. Finally, Hancock Whitney Corp raised its stake in Colgate-Palmolive by 2.3% during the 3rd quarter. Hancock Whitney Corp now owns 12,118 shares of the company’s stock worth $1,258,000 after buying an additional 277 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CL shares. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. TD Cowen decreased their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. UBS Group boosted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $96.59 on Wednesday. The business’s 50 day simple moving average is $97.74 and its 200 day simple moving average is $98.59. Colgate-Palmolive has a 12 month low of $75.50 and a 12 month high of $109.30. The company has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.40 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.